|
TOP NEWS
Drugmaker Aquestive's Brass Sued Over FDA Setback
By Sydney Price
Executives and directors of pharmaceutical company Aquestive Therapeutics Inc. were hit with a shareholder's derivative suit Wednesday accusing them of ignoring deficiencies in a research study for Aquestive's allergic reaction treatment, which eventually prompted the U.S. Food and Drug Administration to reject the company's new drug application.
Complaint attached |
Read full article »
| Save to favorites »
POLICY & REGULATION
LITIGATION
Judge Won't Move 'Maya' Case For Retrial
By Carolina Bolado
A Florida judge on Wednesday denied a hospital's request to move a retrial of Netflix documentary subject Maya Kowalski's claims against the hospital from Sarasota to St. Petersburg, citing the difficulty and expense of moving the 8-year-old case to a new circuit and judge.
2 documents attached |
Read full article »
| Save to favorites »
SURVEYS
EXPERT ANALYSIS
Fraud Enforcement, Sentencing Face Unusual Convergence
The Trump administration’s newly created task force to eliminate fraud and the U.S. Sentencing Commission’s recent proposals to scale back certain elements of the federal sentencing framework seem to point in opposite directions, creating a collision of policy priorities that may reshape how fraud cases are charged, negotiated and sentenced for years to come, says David Tarras at Tarras Defense.
Read full article »
| Save to favorites »
LEGAL INDUSTRY
Ramey Says Sanctions Violation Was 'Misunderstanding'
By Elliot Weld
William Ramey, an intellectual property attorney sanctioned in several federal jurisdictions, told a California federal judge Thursday that any violations of a previous sanctions order regarding his ability to practice law in the state were due to "good-faith misunderstanding of the scope of the court's order — not willful disregard."
Response attached |
Read full article »
| Save to favorites »
|